SAFETY AND IMMUNOGENICITY OF A LIVE RECOMBINANT MEASLES VECTOR BASED CHIKUNGUNYA VACCINE IN HEALTHY ADULTS: A RANDOMIZED, PLACEBO CONTROLLED PHASE 2 STUDY

被引：0
|
作者：
Schrauf, Sabrina [1 ]
Ramsauer, Katrin [1 ]
Muellner, Matthias [1 ]
Pfeiffer, Andrea [1 ]
Kort, Alexander [1 ]
Tauber, Erich [1 ]
机构：
[1] Themis Biosci GmbH, Vienna, Austria
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2017年 / 97卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
2
引用
下载
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [41] Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults
    Halperin, Scott A.
    Das, Rituparna
    Onorato, Matthew T.
    Liu, Kenneth
    Martin, Jason
    Grant-Klein, Rebecca J.
    Nichols, Rick
    Coller, Beth-Ann
    Helmond, Frans A.
    Simon, Jakub K.
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (07): : 1127 - 1135
  • [42] The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: Results of a randomized, placebo-controlled phase 1/2 trial
    Wagena, Edwin J.
    de Vos, Arjen
    Horwith, Gary
    van Schayck, Constant P.
    NICOTINE & TOBACCO RESEARCH, 2008, 10 (01) : 213 - 218
  • [43] Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study
    Berkowitz, Elchonon M.
    Moyle, Graeme
    Stellbrink, Hans-Juergen
    Schuermann, Dirk
    Kegg, Stephen
    Stoll, Matthias
    El Idrissi, Mohamed
    Oostvogels, Lidia
    Heineman, Thomas C.
    JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (08): : 1279 - 1287
  • [44] Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial
    Kim, Leesun
    Liebowitz, David
    Lin, Karen
    Kasparek, Kassandra
    Pasetti, Marcela F.
    Garg, Shaily J.
    Gottlieb, Keith
    Trager, George
    Tucker, Sean N.
    JCI INSIGHT, 2018, 3 (13):
  • [45] A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children
    Breiman, Robert F.
    Brooks, W. Abdullah
    Goswami, Doli
    Lagos, Rosanna
    Borja-Tabora, Charissa
    Lanata, Claudio F.
    Cespedes Londono, Jaime A.
    Lum, Lucy Chai See
    Rappaport, Ruth
    Razmpour, Ahmad
    Walker, Robert E.
    Gruberg, William C.
    Forrest, Bruce D.
    VACCINE, 2009, 27 (40) : 5472 - 5479
  • [46] Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial
    ElSherif, May S.
    Brown, Catherine
    MacKinnon-Cameron, Donna
    Li, Li
    Racine, Trina
    Alimonti, Judie
    Rudge, Thomas L.
    Sabourin, Carol
    Silvera, Peter
    Hooper, Jay W.
    Kwilas, Steven A.
    Kilgore, Nicole
    Badorrek, Christopher
    Ramsey, W. Jay
    Heppner, D. Gray
    Kemp, Tracy
    Monath, Thomas P.
    Nowak, Teresa
    McNeil, Shelly A.
    Langley, Joanne M.
    Halperin, Scott A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (24) : E819 - E827
  • [47] Safety and immunogenicity of dry powder measles vaccine administered by inhalation: A randomized controlled Phase I clinical trial
    Agarkhedkar, Sharad
    Kulkarni, Prasad S.
    Winston, Scott
    Sievers, Robert
    Dhere, Rajeev M.
    Gunale, Bhagwat
    Powell, Ken
    Rota, Paul A.
    Papania, Mark
    VACCINE, 2014, 32 (50) : 6791 - 6797
  • [48] A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naive and flavivirus-experienced healthy adults
    Russell, Kevin L.
    Rupp, Richard E.
    Morales-Ramirez, Javier O.
    Diaz-Perez, Clemente
    Andrews, Charles P.
    Lee, Andrew W.
    Finn, Tyler S.
    Cox, Kara S.
    Falk Russell, Amy
    Schaller, Margaret M.
    Martin, Jason C.
    Hyatt, Donna M.
    Gozlan-Kelner, Sabrina
    Bili, Androniki
    Coller, Beth-Ann G.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [49] Safety and immunogenicity of a recombinant adenovirus vector-based Ebola vaccine
    Grobusch, Martin P.
    Goorhuis, Abraham
    LANCET, 2017, 389 (10069): : 578 - 580
  • [50] Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial
    Hao, B.
    Chen, Z.
    Zeng, G.
    Huang, L.
    Luan, C.
    Xie, Z.
    Chen, J.
    Bao, M.
    Tian, X.
    Xu, B.
    Wang, Y.
    Wu, J.
    Xia, S.
    Yuan, L.
    Huang, J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (08) : 1026 - 1031
12345